Weakened Cash ConversionOperating cash flow lagging net income and a sharp ~37% drop in free cash flow indicate working-capital or investment strain. If this persists, the company may face reduced internal funding for R&D, inventories, or contract fulfilment, weakening long-term cash resilience.
Margin Compression Since 2024A material decline in net margin from ~17% to ~12% suggests mix shifts, rising costs, or normalization after peak results. Sustained margin erosion would reduce free cash flow and returns, undermining the company's competitive advantage in pricing and long-term profitability.
Recent Top-Line And EPS WeaknessRecent negative revenue growth (~-3.3%) and substantial EPS decline (~-25%) point to demand softness or timing in tender-based sales. Persistent top-line and earnings weakness could impair scale benefits, pressure margins, and limit funding for product development over the next several months.